Disruption of endothelial cell intraflagellar transport protein 88 exacerbates doxorubicin-induced cardiotoxicity
Authors:
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 260, 118216
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (MOP# 378189)
This publication has 16 references indexed in Scilit:
- Doxorubicin-Induced Systemic Inflammation Is Driven by Upregulation of Toll-Like Receptor TLR4 and Endotoxin LeakageCancer Research, 2016
- Tyrosine Phosphatase PTPRJ/DEP-1 Is an Essential Promoter of Vascular Permeability, Angiogenesis, and Tumor ProgressionCancer Research, 2016
- Deficiency in Cardiolipin Reduces Doxorubicin-Induced Oxidative Stress and Mitochondrial Damage in Human B-LymphocytesPLOS ONE, 2016
- Protective effect of ocotillol against doxorubicin-induced acute and chronic cardiac injuryMolecular Medicine Reports, 2013
- Flow detection and calcium signalling in vascular endothelial cellsCardiovascular Research, 2013
- A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart diseaseBlood, 2010
- Doxorubicin CardiomyopathyCardiology, 2009
- Anthracycline associated cardiotoxicity in survivors of childhood cancerHeart, 2008
- Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous InfusionAnnals of Internal Medicine, 1982
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979